Related Experiment Video
Updated: Jul 5, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial dysfunction in donor hearts. A possible etiology.
V J Owen1, P B Burton, M C Michel
1Cardiothoracic Surgery, National Heart and Lung Institute at Imperial College School of Medicine, London, UK. v.j.owen@ic.ac.uk
Increased inhibitory G protein Gialpha activity contributes to impaired contractility in acutely failing donor hearts. This contrasts with changes in calcium-handling proteins and beta-adrenoceptor density, which were not common causes.
Area of Science:
- Cardiology
- Molecular Biology
- Transplantation Science
Background:
- Unused donor hearts often exhibit myocardial dysfunction, rendering them unsuitable for transplantation.
- The underlying mechanisms of acute heart failure in these hearts remain unclear.
- This study investigates potential causes including calcium-handling proteins, beta-adrenoceptor density, and inhibitory G protein Gialpha.
Purpose of the Study:
- To determine the molecular basis of contractile dysfunction in acutely failing donor hearts.
- To compare alterations in unused donor hearts with those in end-stage failing and nonfailing hearts.
- To identify key protein targets contributing to impaired cardiac function.
Main Methods:
- Analysis of myocardial samples from unused donor hearts (ejection fraction <30%), end-stage failing hearts, and nonfailing hearts.
- In vitro assessment of inotropic function in trabeculae and isolated myocytes.
- Quantification of specific calcium-handling proteins (SERCA, NCX), beta-adrenoceptor density, and Gialpha activity.
Main Results:
- Unused donor hearts showed contractile dysfunction comparable to failing hearts.
- Alterations in sarcoplasmic reticulum calcium-ATPase and sodium-calcium exchanger abundance were not common to both groups.
- Beta-adrenoceptor density was reduced in failing hearts but not in unused donor hearts.
- Increased inhibitory G protein Gialpha activity was observed in both unused donor and failing hearts.
Conclusions:
- Elevated Gialpha activity is a significant factor in the impaired contractility of acutely failing donor hearts.
- This finding differentiates the mechanism from alterations in calcium-handling proteins or beta-adrenoceptor density.
- Targeting Gialpha may offer therapeutic potential for preserving cardiac function in donor hearts.
Related Concept Videos
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease I: Introduction
Kidney Transplant I: Introduction

